Recombinant interleukin-2 based treatments for advanced melanoma: The experience of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group
SourceCancer Journal, 3, (1997), pp. S22-S28
Article / Letter to editor
Display more detailsDisplay less details
SubjectAntigen-Presenting Cells; Bacterial Infections; Biomedical Engineering; Blood Cells; Blood Component Removal; Cells, Cultured; Chemotactic Factors; Combined Modality Therapy; Dendritic Cells; Epithelial Cells (Non MeSH); Gene Therapy; Hemic and Immune Systems (Non MeSH); Immunologic Techniques; Immunotherapy; Infection; Leukemia; Lymphoma; Magnetic Resonance Imaging; Melanocytes; Monocytes; Mycoses; Phagocytes; Tissue Culture
Upload full text
Use your RU credentials (u/z-number and password) tolog in with SURFconextto upload a file for processing by the repository team.